Group 1 (n=32) (paracetamol) | Group 2 (n=33) (placebo) | p Value | |
---|---|---|---|
Facial action (%) | |||
Baseline | 22.2 (39.5) | 30.2 (55.1) | 0.50 |
Heel prick (overall) | 143.5 (54.2) | 131.1 (59.6) | 0.38 |
Prick phase | 174.2 (64.2) | 184.0 (64.9) | 0.54 |
Squeeze phase | 227.6 (44.7) | 203.6 (75.2) | 0.12 |
Recovery phase | 73.3 (74.2) | 57.8 (71.5) | 0.39 |
Cry (%) | |||
Baseline | 0.0 (0) | 1.3 (7.7) | 0.33 |
Heel prick (overall) | 29.4 (19.9) | 26.8 (20.2) | 0.60 |
Prick phase | 37.3 (30.6) | 39.3 (29.4) | 0.79 |
Squeeze phase | 51.4 (27.1) | 44.3 (30.5) | 0.32 |
Recovery phase | 10.1 (18.5) | 8.7 (21.3) | 0.78 |
↵2-150 Figures are mean (SD).